218 related articles for article (PubMed ID: 28971860)
41. Immunosuppression and parasitic diseases: experimental Schistosomiasis mansoni.
Gargione C; Vellosa SA; Hoshino-Shimizu S; Okumura M; Chiodelle SG
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(3):122-8. PubMed ID: 10436644
[TBL] [Abstract][Full Text] [Related]
42. In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni.
Queiroz LS; Ferreira EA; Mengarda AC; Almeida ADC; Pinto PF; Coimbra ES; de Moraes J; Denadai ÂML; Da Silva Filho AA
Parasitol Res; 2021 Apr; 120(4):1321-1333. PubMed ID: 33164156
[TBL] [Abstract][Full Text] [Related]
43. Schistosoma mansoni: acquired immunity in mice after the use of oxamniquine at the evolutive skin and pulmonary phases.
Coelho PM; Mello RT; Gerken SE
Rev Inst Med Trop Sao Paulo; 1991; 33(1):28-31. PubMed ID: 1843393
[TBL] [Abstract][Full Text] [Related]
44. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice.
Doenhoff MJ; Sabah AA; Fletcher C; Webbe G; Bain J
Trans R Soc Trop Med Hyg; 1987; 81(6):947-51. PubMed ID: 3140436
[TBL] [Abstract][Full Text] [Related]
45. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
46. Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni.
Dias LC; Olivier CE
Rev Inst Med Trop Sao Paulo; 1986; 28(5):352-7. PubMed ID: 3589395
[No Abstract] [Full Text] [Related]
47. Drug resistance in schistosomiasis.
Coles GC; Bruce JI; Kinoti GK; Mutahi WT; Dias EP; Katz N
Trans R Soc Trop Med Hyg; 1986; 80(2):347. PubMed ID: 3787696
[No Abstract] [Full Text] [Related]
48. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Parasit Vectors; 2020 Sep; 13(1):474. PubMed ID: 32933556
[TBL] [Abstract][Full Text] [Related]
49. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.
Thiong'o FW; Mbugua GG; Ouma JH; Sturrock RK
East Afr Med J; 2002 Jan; 79(1):29-33. PubMed ID: 12380867
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
Campos R; Pinto PL; Amato Neto V; Moreira AA
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
[TBL] [Abstract][Full Text] [Related]
52. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
[TBL] [Abstract][Full Text] [Related]
53. Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection.
Vimieiro AC; Araújo N; Katz N; Kusel JR; Coelho PM
Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):881-6. PubMed ID: 24271044
[TBL] [Abstract][Full Text] [Related]
54. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis.
Lambertucci JR; Modha J; Curtis R; Doenhoff M
Trans R Soc Trop Med Hyg; 1989; 83(3):354-7. PubMed ID: 2515622
[TBL] [Abstract][Full Text] [Related]
55. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
56. Combined treatment of Biomphalaria glabrata infected by Schistosoma mansoni with oxamniquine and praziquantel: Reproductive histological and metabolic aspects.
Lima RN; Coelho PMZ; Mattos ACA; Mello Silva CC; Augusto RC; Mota EM; de Souza S; Atella GC; Cabral SS; Gabriel Kluck GE; Faro MJ
Exp Parasitol; 2017 Dec; 183():6-12. PubMed ID: 29017937
[No Abstract] [Full Text] [Related]
57. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
[TBL] [Abstract][Full Text] [Related]
58. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
Lamberton PHL; Faust CL; Webster JP
Infect Dis Poverty; 2017 Jun; 6(1):110. PubMed ID: 28622767
[TBL] [Abstract][Full Text] [Related]
59. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
Nessim NG; Demerdash Z
Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
[TBL] [Abstract][Full Text] [Related]
60. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
Alwan SN; Taylor AB; Rhodes J; Tidwell M; McHardy SF; LoVerde PT
PLoS Pathog; 2023 Jul; 19(7):e1011018. PubMed ID: 37428793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
